LLMpediaThe first transparent, open encyclopedia generated by LLMs

ELISA

Generated by Llama 3.3-70B
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: HIV/AIDS Hop 4
Expansion Funnel Raw 106 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted106
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
ELISA
NameELISA
FullnameEnzyme-Linked Immunosorbent Assay

ELISA is a widely used laboratory technique developed by Sasha Machovich, Peter Perlmann, and Eva Engvall at the University of Stockholm and University of Helsinki in the early 1970s. This technique has been extensively used in various fields, including immunology, molecular biology, and biochemistry, to detect and quantify antibodies or antigens in a sample, often in collaboration with organizations like the World Health Organization and the National Institutes of Health. The development of ELISA has been influenced by the work of renowned scientists such as Jonas Salk, Albert Sabin, and Edward Jenner, who have contributed to the understanding of vaccination and immunization through their work at institutions like the University of Pittsburgh and the Institute of Medicine. ELISA has become an essential tool in many laboratories, including those at the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control.

Introduction to ELISA

ELISA is a versatile technique that has been used in various applications, including the diagnosis of infectious diseases such as HIV, tuberculosis, and malaria, which are major concerns for organizations like the World Health Organization and the Bill and Melinda Gates Foundation. The technique has also been used in cancer research at institutions like the National Cancer Institute and the American Cancer Society, as well as in the development of vaccines by companies like Pfizer and GlaxoSmithKline. ELISA has been employed in the study of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus at research centers like the University of California, San Francisco and the Johns Hopkins University. The technique has been used in conjunction with other methods, such as Western blot and polymerase chain reaction (PCR), to detect and analyze biomarkers at institutions like the National Institute of Environmental Health Sciences and the European Molecular Biology Laboratory.

Principle of ELISA

The principle of ELISA is based on the binding of antibodies to antigens, which is a fundamental concept in immunology and has been studied by researchers like Niels Kaj Jerne and Rodney Porter at institutions like the University of Copenhagen and the University of Oxford. The technique involves the use of an enzyme-linked antibody that binds to the antigen of interest, which is often provided by companies like Sigma-Aldrich and Thermo Fisher Scientific. The enzyme converts a substrate into a detectable product, which is measured using a spectrophotometer or other detection systems, such as those developed by Beckman Coulter and PerkinElmer. This principle has been applied in various fields, including clinical chemistry and molecular diagnostics, at institutions like the Mayo Clinic and the University of California, Los Angeles.

Types of ELISA

There are several types of ELISA, including direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA, which have been developed and used by researchers at institutions like the University of Cambridge and the Massachusetts Institute of Technology. Each type of ELISA has its own advantages and disadvantages, and the choice of which one to use depends on the specific application and the antibodies and antigens involved, as well as the equipment and reagents available from companies like BD Biosciences and Bio-Rad Laboratories. For example, direct ELISA is often used for the detection of antigens in a sample, while indirect ELISA is used for the detection of antibodies, and has been used in studies on influenza and Ebola at institutions like the Centers for Disease Control and Prevention and the World Health Organization.

Applications of ELISA

ELISA has a wide range of applications in various fields, including clinical diagnostics, research, and quality control, at institutions like the Food and Drug Administration and the European Medicines Agency. The technique is used to detect and quantify biomarkers for diseases such as cancer, infectious diseases, and autoimmune diseases, which are major concerns for organizations like the American Red Cross and the International Federation of Red Cross and Red Crescent Societies. ELISA is also used in the development of vaccines and therapeutic antibodies by companies like Merck & Co. and AstraZeneca, as well as in the study of immunological responses to infections and vaccinations at research centers like the University of Oxford and the University of California, Berkeley.

ELISA Procedure

The ELISA procedure typically involves several steps, including the preparation of the sample, the coating of the microtiter plate with the antigen or antibody, the addition of the sample and the enzyme-linked antibody, and the measurement of the signal using a spectrophotometer or other detection systems, such as those developed by Tecan Group and Molecular Devices. The procedure can be automated using robotics and software developed by companies like Thermo Fisher Scientific and PerkinElmer, which are often used in laboratories at institutions like the National Institutes of Health and the European Molecular Biology Laboratory. The choice of reagents and equipment can affect the sensitivity and specificity of the assay, and has been studied by researchers at institutions like the University of California, San Diego and the University of Washington.

Interpretation of ELISA Results

The interpretation of ELISA results requires careful consideration of several factors, including the sensitivity and specificity of the assay, the positive predictive value and negative predictive value, and the reference range for the biomarker being measured, which are often established by organizations like the Clinical and Laboratory Standards Institute and the International Organization for Standardization. The results can be affected by various factors, such as the quality of the reagents and equipment, the experience of the operator, and the sample handling and storage procedures, which are critical in laboratories at institutions like the Centers for Disease Control and Prevention and the World Health Organization. The interpretation of ELISA results is often performed in conjunction with other diagnostic tests, such as Western blot and polymerase chain reaction (PCR), to confirm the diagnosis and monitor the treatment of diseases, which is a common practice at institutions like the Mayo Clinic and the University of California, Los Angeles.

Category: Laboratory techniques